# VA106483 Dose Response in Females

> **NCT01171391** · PHASE1 · COMPLETED · sponsor: **Vantia Ltd** · enrollment: 21 (actual)

## Conditions studied

- Nocturia

## Interventions

- **DRUG:** VA106483
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01171391
- **Lead sponsor:** Vantia Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2010-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01171391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01171391, "VA106483 Dose Response in Females". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01171391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*